pubrio
NMPA-National Medical Products Administration logo

NMPA-National Medical Products Administration

Government Agency
nmpa.gov.cn
健康与人类服务4 employeesFounded 1950🇨🇳 中国

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

成立年份
1950
员工人数
4
行业
健康与人类服务
公司类型
Government Agency
总部
🇨🇳Beijing, Beijing
专长
健康与人类服务
4 / 13
活跃市场
2
新市场
MO · TW
置信度
多为早期信号
+300%
势头
较上一周期
19 / 100
扩张评分
早期
阶段12探索中1投入中
5 个信号 · 最近 90 天

全球扩张

实时
HKAUJP
阶段
探索中投入中进入中运营中
+10个市场已锁定
已显示 13 个中的 3 个

解锁市场时间线与信号动态

活动脉搏

新增 合作伙伴 活动 — 刚出现 3 个新信号。

最近 90 天
招聘
0
无活动
营销与公关
0
无活动
产品与技术
2
产品发布
+2个类别已锁定
已显示 5 个中的 3 个

市场进入时间线

该公司进入各个市场的顺序 — 从最早到最新

1
🇭🇰HK进入的第 1st 个市场 · 2025推进中
投入中
14 个信号投入中 阶段
2
🇦🇺AU进入的第 2nd 个市场 · 2025推进中
探索中
6 个信号探索中 阶段
3
🇯🇵JP进入的第 3rd 个市场 · 2025推进中
探索中
4 个信号探索中 阶段
+10个市场已锁定
已显示 13 个中的 3 个
当前阶段投入中投入资源
置信度41%
开始追踪于2025首个信号

近期信号

产品发布🇭🇰 HK2周前

安腾基因获CDE批准进行ATG-022三期试验

合作伙伴🇭🇰 HK上个月

科伦博泰获SKB118临床试验批准

注册以查看完整信号动态

了解一下

关于 NMPA-National Medical Products Administration 的常见问题

关于 NMPA-National Medical Products Administration 的业务、市场和增长信号的快速解答。

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。